Pharmafile Logo
Pharmafocus logo
Advanced Search

QALY

Showing 11 posts of 11 posts found.

praluent_75mg_pen_box_hr

Amgen, Sanofi cholesterol medicines “not cost-effective”, need to drop price by two-thirds

August 17, 2016
Research and Development, Sales and Marketing Amgen, QALY, Regeneron, Repatha, Sanofi, cost effective, cost-effective, praluent

A new study published in JAMA has suggested that Amgen, Sanofi and Regeneron would have to reduce their prices for …

News

Nice rejects BMS’ immunotherapy Opdivo for previously treated kidney cancer on pricing

July 5, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Bristol-Myers Squibb, NICE, QALY, immunotherapy, opdivo, regulation

UK regulators have rejected Bristol-Myers Squibb’s (NYSE: BMY) immunotherapy Opdivo for previously treated kidney cancer on pricing and substantial uncertainty …

News

NICE is ‘setting prices too high’ for NHS

February 19, 2015
Sales and Marketing ABPI, NHS, NICE, QALY, costs, health, pharma

The cost threshold NICE uses when approving drugs is too high and is doing more harm than good, new research …

News
jonathan_emms_close

ABPI president: NICE needs political reform

June 17, 2014
Business Services, Medical Communications, Research and Development ABPI, NHS, NICE, Pfizer, QALY, emms, jonathan, vba

NICE needs to be reformed with its QALY formula heavily revised if it is to meet the challenges of 21st …

News

NICE: new system will allow more drugs on NHS

February 17, 2014
Sales and Marketing DH, Dillon, DoH, NHS, NICE, QALY

NICE has said that it will be able to approve more medicines under a new drug pricing policy, but warns …

News
NICE image

NICE hits back at ‘limited’ EC study

January 28, 2013
Sales and Marketing ABPI, EC, NHS, NICE, QALY, Whitehead

NICE has delivered a robust defence of the methods by which it arrives at a judgment on the value of …

News
NICE image

NICE: ‘lot of work’ to do on VBP

November 30, 2012
Medical Communications, Sales and Marketing Boysen, NHS, NICE, QALY, VBP

NICE is still working out what its role with the new NHS Commissioning Board will be, with other key issues …

News
Whitehead image

NICE bows to industry pressure

August 21, 2012
Sales and Marketing ABPI, NICE, QALY, VBP

NICE has bowed to industry pressure and will allow independent advisors to sit on its appeals board. An appeal can …

News
Zelboraf image

NICE still minded not to recommend Zelboraf

August 9, 2012
Sales and Marketing BMS, NICE, QALY, Yervoy, Zelboraf

NICE is asking Roche for more information about its melanoma pill Zelboraf, saying it is still too expensive and its …

News

Health Bill continues fast pace of NHS reform

January 20, 2011
Sales and Marketing GP consortia, NHS, NHS Commissioning Board, NHS reforms, NICE, QALY

The government has outlined its draft Health and Social Care Bill, making some minor concessions to critics but promising no …

News

NICE ‘surprised’ at downgrading of its role

November 5, 2010
Sales and Marketing Andrew Dillon, GP prescribing deicisions, NICE, QALY, incremental cost-effectiveness ratio, value-based pricing

NICE received no warning that its health technology assessment role is to be downgraded, the watchdog’s head has admitted. In …

News
The Gateway to Local Adoption Series

Latest content

Teva announces positive results from trial of AJOVY for migraine

December 5, 2025

Vetter announces leadership transition as Thomas Otto retires

December 5, 2025

Samsung Bioepis announces launch of two new denosumab biosimilars in Europe

December 4, 2025

Medicus Pharma appoints Carolyn Bonner as CFO

December 4, 2025

Sandoz launches two new bone disease biosimilars in Europe

December 3, 2025